SCHEMBL3400325

SCHEMBL3400325

CCC(C)c1cc(Cl)cc(C(C)CC)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.61
GABRB1 P18505 4/20 0.61
TSHR P16473 4/20 0.47
RORC P51449 1/20 0.43
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
ALDH1A1 P00352 4/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP3A4 P08684 2/20 0.37
RECQL P46063 1/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11682443 0.94 GABRA1 (0.55) GABRA1GABRB1TSHRRORCCA1
SCHEMBL9797399 0.90 GABRA1 (0.50) GABRA1GABRB1TSHRRORCCA1
SCHEMBL11679871 0.87 GABRA1 (0.47) GABRA1GABRB1TSHRRORCALDH1A1
SCHEMBL2168125 0.84 RORC (0.46) GABRA1GABRB1TSHRRORCALDH1A1
SCHEMBL10946690 0.82 CA1 (0.58) GABRA1GABRB1TSHRRORCCA1
SCHEMBL1836944 0.80 TSHR (0.48) GABRA1GABRB1TSHRRORCCA1
SCHEMBL6943323 0.80 TSHR (0.48) GABRA1GABRB1TSHRRORCCA1
SCHEMBL8469992 0.79 RORC (0.58) GABRA1GABRB1TSHRRORCALDH1A1
SCHEMBL9182058 0.79 MAPT (0.41) GABRA1GABRB1TSHRRORCALDH1A1
SCHEMBL9182063 0.79 MAPT (0.41) GABRA1GABRB1TSHRRORCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2301908-B1 (-)-stereoisomer of 2,6-di-sec-butylphenol and analogs thereof for promoting antiemetic effect, treatment of nausea and vomiting and treatment of migraine SIGNATURE THERAPEUTICS INC (US) 2014-06-25 EP disclosed
EP-2146946-B1 (-)- stereoisomer of 2,6-di-sec-butylphenol and analogs thereof PHARMACOFORE INC (US) 2010-11-10 EP disclosed
US-3933927-A Phenol transalkylation process ETHYL CORPORATION (US) 1976-01-20 US disclosed